Browse > Article
http://dx.doi.org/10.3961/jpmph.2009.42.6.349

Identification and Application of Biomarkers in Molecular and Genomic Epidemiologic Research  

Lee, Kyoung-Mu (Clinical Research Institute, Seoul National University Hospital)
Han, So-Hee (Department of Preventive Medicine, Seoul National University College of Medicine)
Park, Woong-Yang (Department of Biochemistry, Seoul National University College of Medicine)
Kang, Dae-Hee (Department of Preventive Medicine, Seoul National University College of Medicine)
Publication Information
Journal of Preventive Medicine and Public Health / v.42, no.6, 2009 , pp. 349-355 More about this Journal
Abstract
Biomarkers are characteristic biological properties that can be detected and measured in a variety of biological matrices in the human body, including the blood and tissue, to give an indication of whether there is a threat of disease, if a disease already exists, or how such a disease may develop in an individual case. Along the continuum from exposure to clinical disease and progression, exposure, internal dose, biologically effective dose, early biological effect, altered structure and/or function, clinical disease, and disease progression can potentially be observed and quantified using biomarkers. While the traditional discovery of biomarkers has been a slow process, the advent of molecular and genomic medicine has resulted in explosive growth in the discovery of new biomarkers. In this review, issues in evaluating biomarkers will be discussed and the biomarkers of environmental exposure, early biologic effect, and susceptibility identified and validated in epidemiological studies will be summarized. The spectrum of genomic approaches currently used to identify and apply biomarkers and strategies to validate genomic biomarkers will also be discussed.
Keywords
Biomarker; Molecular epidemiology; Genomic epidemiology; Validity; Exposure;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007; 47: 513-539   DOI   PUBMED   ScienceOn
2 Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406(6797): 747-752   DOI   ScienceOn
3 Anderson NL, Taylor J, Hofmann JP, Esquer- Blasco R, Swift S, Anderson NG. Simultaneous measurement of hundreds of liver proteins: Application in assessment of liver function. Toxicol Pathol 1996; 24(1): 72-76   DOI   ScienceOn
4 Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19(3): 242-247   DOI   ScienceOn
5 Cutler P. Protein arrays: The current state-ofthe- art. Proteomics 2003; 3(1): 3-18   DOI   PUBMED   ScienceOn
6 Khoury MJ, Dorman JS. The human genome epidemiology network. Am J Epidemiol 1998; 148(1): 1-3   DOI   PUBMED   ScienceOn
7 Strickland PT, Qian Z, Friesen MD, Rothman N, Sinha R. Metabolites of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in human urine after consumption of charbroiled or fried beef. Mutat Res 2002; 506-507: 163-173   DOI   PUBMED   ScienceOn
8 Lee KM, Kang D, Lee SJ, Park SK, Lee KH, Choi JY, et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 2006; 16(5): 1035-1039   PUBMED
9 Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, et al. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 2005; 11(12): 4620-4626   DOI   ScienceOn
10 McDonald SA, Hutchinson SJ, Bird SM, Robertson C, Mills PR, Dillon JF, et al. A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland. Br J Cancer 2008; 99(5): 805-810   DOI   ScienceOn
11 Yoo KY, Kang D. Current researches on breast cancer epidemiology in Korea. Breast Cancer 2003; 10(4): 289-293   DOI   ScienceOn
12 Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297(18): 2010-2017   DOI   ScienceOn
13 Park WY, Hwang CI, Kang MJ, Seo JY, Chung JH, Kim YS, et al. Gene profile of replicative senescence is different from progeria or elderly donor. Biochem Biophys Res Commun 2001; 282(4): 934-939   DOI   ScienceOn
14 Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286(5439): 531-537   DOI   PUBMED   ScienceOn
15 Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, et al. The HRAS1 minisatellite locus and risk of ovarian cancer. Cancer Res 2000; 60(2): 259-261   PUBMED
16 Zhuo X, Cai L, Xiang Z, Li Q, Zhang X. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: An evidencebased meta-analysis. J Exp Clin Cancer Res 2009; 28: 46   DOI   ScienceOn
17 Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A metaanalysis. Int J Med Sci 2007; 4(2): 59-71   PUBMED
18 Lee SA, Lee KM, Park WY, Kim B, Nam J, Yoo KY, et al. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 2005; 37(2): 86-90   DOI   ScienceOn
19 Chatterjee SK, Zetter BR. Cancer biomarkers: Knowing the present and predicting the future. Future Oncol 2005; 1(1): 37-50   DOI   ScienceOn
20 Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285(1): 47-51   DOI   ScienceOn
21 Van Maele-Fabry G, Duhayon S, Mertens C, Lison D. Risk of leukaemia among pesticide manufacturing workers: A review and metaanalysis of cohort studies. Environ Res 2008;106(1):121-137   DOI   ScienceOn
22 Kim JH, Ha IS, Hwang CI, Lee YJ, Kim J, Yang SH, et al. Gene expression profiling of anti-GBM glomerulonephritis model: The role of NF-kappaB in immune complex kidney disease. Kidney Int 2004; 66(5): 1826-1837   DOI   ScienceOn
23 Yang CX, Matsuo K, Wang ZM, Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol 2005; 11(17): 2531-2538   DOI
24 Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822): 860-921   DOI   ScienceOn
25 Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344(15): 1125-1131   DOI   ScienceOn
26 Holmes E, Nicholson JK, Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol 2001; 14(2): 182-191   DOI   ScienceOn
27 Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008; 5(10): 588-599   DOI   ScienceOn
28 Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008; 113(4): 750-757   DOI   ScienceOn
29 Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a metaanalysis of prospective studies. Int J Cancer 2009. Epub 2009 Oct 6   DOI   ScienceOn
30 Van‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415(6871): 530-536   DOI   PUBMED   ScienceOn
31 Gunter MJ, Divi RL, Kulldorff M, Vermeulen R, Haverkos KJ, Kuo MM, et al. Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis 2007; 28(7): 1426-1429   DOI   ScienceOn
32 Woo HG, Park ES, Lee JS, Lee YH, Ishikawa T, Kim YJ, et al. Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res 2009; 69(9): 4059-4066   DOI   ScienceOn
33 Tokuhisa Y, Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, et al. Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. Br J Cancer 2007; 97(10): 1399-1403   DOI   ScienceOn
34 Bonassi S, Norppa H, Ceppi M, Stromberg U, Vermeulen R, Znaor A, et al. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22,358 subjects in 11 countries. Carcinogenesis 2008; 29(6): 1178-1183   DOI   ScienceOn
35 Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162(10): 925-942   DOI   ScienceOn
36 Brown PO, Botstein D. Explorin the new world of the genome with DNA microarrays. Nat Genet 1999; 21(1 Suppl): 33-37   DOI   PUBMED   ScienceOn
37 Schulte PA. A conceptual and historical framework for molecular epidemiology. In: Schulte PA, Perera FP, editors. Molecular Epidemiology: Principles and Practices. San Diego: Academic Press; 1993. p. 1-36
38 Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, et al. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2009; 18(3): 846-853   DOI   ScienceOn
39 Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775(1): 138-162   DOI   PUBMED   ScienceOn
40 Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 2008; 7(12): 3655-3660   DOI   ScienceOn
41 Collings FB, Vaidya VS. Novel technologies for the discovery and quantitation of biomarkers of toxicity. Toxicology 2008; 245(3): 167-174   DOI   ScienceOn
42 Kang D, Lee KH, Lee KM, Kwon HJ, Hong YC, Cho SH, et al. Design issues in crosssectional biomarkers studies: Urinary biomarkers of PAH exposure and oxidative stress. Mutat Res 2005; 592(1-2): 138-146   DOI   PUBMED   ScienceOn
43 Park WY, Hwang CI, Im CN, Kang MJ, Woo JH, Kim JH, et al. Identification of radiationspecific responses from gene expression profile. Oncogene 2002; 21(55): 8521-8528   DOI   ScienceOn
44 Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, et al. Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: A pooled analysis. Cancer Epidemiol Biomarkers Prev 2005; 14(7): 1747-1753   DOI   ScienceOn
45 Van Maele-Fabry G, Libotte V, Willems J, Lison D. Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes Control 2006; 17(4): 353-373   DOI   ScienceOn
46 Rundle AG, Vineis P, Ahsan H. Design Options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev 2005; 14(8): 1899-1907   DOI   ScienceOn
47 Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(6): 1184-1188   DOI   ScienceOn
48 Lee DH, Kim EG, Park KS, Jeong SW, Kong ID, Lee JW. Characteristics of P2X7-like receptor activated by adenosine triphosphate in HIT-T15 cells. Pancreas 2007; 35(1): 53-62   DOI   ScienceOn
49 Robertson DG, Reily MD, Baker JD. Metabonomics in preclinical drug development. Expert Opin Drug Metab Toxicol 2005; 1(3): 363-376   DOI   ScienceOn
50 Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12(12):1509-1517
51 Li H, Ha TC, Tai BC. XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysis. Breast 2009; 18(3): 183-191   DOI   ScienceOn
52 Bensalah K, Montorsi F, Shariat SF. Challenges of cancer biomarker profiling. Eur Urol 2007; 52(6): 1601-1609   DOI   ScienceOn
53 Yates JR 3rd. Mass spectrometry: From genomics to proteomics. Trends Genet 2000; 16(1): 5-8   DOI   ScienceOn
54 Lee MS, Jun DH, Hwang CI, Park SS, Kang JJ, Park HS, et al. Selection of neural differentiation-specific genes by comparing profiles of random differentiation. Stem Cells 2006; 24(8): 1946-1955   DOI   ScienceOn
55 Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature 2006; 444(7118): 444-454   DOI   ScienceOn